A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations (Q34571839)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations |
scientific article |
Statements
1 reference
A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations (English)
1 reference
H Asahina
1 reference
K Yamazaki
1 reference
I Kinoshita
1 reference
N Sukoh
1 reference
M Harada
1 reference
H Yokouchi
1 reference
T Ishida
1 reference
S Ogura
1 reference
T Kojima
1 reference
Y Okamoto
1 reference
Y Fujita
1 reference
H Dosaka-Akita
1 reference
H Isobe
1 reference
M Nishimura
1 reference
1 October 2006
1 reference
1 reference
95
1 reference
8
1 reference
998-1004
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference